Communicable Disease Prevention and Control Services, British Columbia Centre for Disease Control (BCCDC), Vancouver; Canada.
Clin Infect Dis. 2012 Feb 1;54(3):318-27. doi: 10.1093/cid/cir836. Epub 2011 Dec 8.
Parental immunization has been recommended as a "cocoon" strategy to prevent serious pertussis outcomes in early infancy. We illustrate the high number needed to vaccinate (NNV) for this program based on recent epidemiologic data from the provinces of Québec and British Columbia (BC), Canada.
Surveillance trends were summarized for the period 1990-2010. Hospitalization, intensive care unit (ICU) admission, and mortality data were compiled from 2000 to 2009. The proportion of infant pertussis attributed to a parent was estimated at 35%, explored up to 55%. Adult vaccine efficacy (VE) was estimated at 85%. The NNV was calculated as [2 parents/(parent-attributable infant risk × parent VE)]. To capture at least 1 recent cyclical peak, NNV was derived for the period 2005-2009 and explored for peak/trough years.
Substantial decline has occurred in pertussis incidence across all age groups including infants, reaching a 20-year nadir in 2010 in both provinces. For the period 2005-2009, the risk of infant hospitalization and ICU admission was 57 and 7, respectively, per 100 000 in Québec and 33 and 7, respectively, per 100 000 in BC. In both provinces the risk of infant pertussis-related death over that period was <0.5 per 100 000. The NNV for parental immunization was at least 1 million to prevent 1 infant death, approximately 100 000 for ICU admission, and >10 000 for hospitalization.
In the context of low pertussis incidence, the parental cocoon program is inefficient and resource intensive for the prevention of serious outcomes in early infancy. Regions contemplating the cocoon program should consider the NNV based on local epidemiology.
父母免疫接种已被推荐为预防婴儿早期严重百日咳结局的“茧”策略。我们根据加拿大魁北克省和不列颠哥伦比亚省(BC)最近的流行病学数据,说明了该计划所需的接种人数(NNV)。
总结了 1990 年至 2010 年的监测趋势。从 2000 年至 2009 年收集了住院、重症监护病房(ICU)入院和死亡率数据。估计婴儿百日咳归因于父母的比例为 35%,最高可达 55%。成人疫苗效力(VE)估计为 85%。NNV 计算为[2 名父母/(父母归因于婴儿的风险×父母 VE)]。为了至少捕获一个最近的周期性高峰,对 2005-2009 年期间的 NNV 进行了推导,并对高峰/低谷年份进行了探索。
包括婴儿在内的所有年龄组的百日咳发病率均大幅下降,在两个省份均达到 20 年的最低点。在 2005-2009 年期间,魁北克省婴儿住院和 ICU 入院的风险分别为每 100 000 人 57 人和 7 人,不列颠哥伦比亚省分别为每 100 000 人 33 人和 7 人。在这两个省份,在此期间婴儿百日咳相关死亡的风险均<0.5/100 000。预防 1 例婴儿死亡,父母免疫接种的 NNV 至少为 100 万,预防 ICU 入院的 NNV 约为 10 万,预防住院的 NNV 超过 1 万。
在百日咳发病率较低的情况下,父母的“茧”计划对于预防婴儿早期严重结局效率低下且资源密集。考虑“茧”计划的地区应根据当地流行病学考虑 NNV。